Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses
about
Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionCannabinoids and Epilepsy.GPR55 deletion in mice leads to age-related ventricular dysfunction and impaired adrenoceptor-mediated inotropic responses.Synaptic enhancement induced by gintonin via lysophosphatidic acid receptor activation in central synapses.Multidrug resistance protein 1 (MRP1, ABCC1), a "multitasking" ATP-binding cassette (ABC) transporter.Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages.Molecular Targets of Cannabidiol in Neurological DisordersTime-Resolved Imaging Reveals Heterogeneous Landscapes of Nanomolar Ca(2+) in Neurons and Astroglia.Role of GPR55 during Axon Growth and Target Innervation.Diacylglycerol lipase α manipulation reveals developmental roles for intercellular endocannabinoid signalingRod photoreceptors express GPR55 in the adult vervet monkey retina.Astrocytic GABA transporter activity modulates excitatory neurotransmission.Nanoscale diffusion in the synaptic cleft and beyond measured with time-resolved fluorescence anisotropy imagingThe endocannabinoid system and appetite: relevance for food reward.Age dependent plasticity in endocannabinoid modulation of pain processing through postnatal development.Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent Epilepsy?G protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homoeostasis.Altering the course of schizophrenia: progress and perspectives.Advances in the Physiology of GPR55 in the Central Nervous System.Beyond radio-displacement techniques for identification of CB1 ligands: the first application of a fluorescence-quenching assay.Molecular Pharmacology of Phytocannabinoids.Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and miceNeuro-psychopharmacological perspective of Orphan receptors of Rhodopsin (class A) family of G protein-coupled receptors.Palmitoylethanolamide Modulates GPR55 Receptor Signaling in the Ventral Hippocampus to Regulate Mesolimbic Dopamine Activity, Social Interaction, and Memory Processing.A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum.The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial orbital cortex of mice with acute stress.Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome.A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity.Scotopic vision in the monkey is modulated by the G protein-coupled receptor 55.LH-21 and abnormal cannabidiol improve β-cell function in isolated human and mouse islets through GPR55-dependent and -independent signalling.GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans.Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model.Reefer to the Rescue: The Dope on Cannabidiol as a Multi-Symptom Panacea for Dravet Syndrome.A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
P2860
Q27014154-4AE7D8FE-1E65-4EC3-AEEB-14588FC2FD09Q27336451-98BD928B-D04A-4B40-9C7C-254042E7F29AQ34282113-0C0B5663-5C96-4584-BAE0-D4D4BFE26A83Q34453783-4F867D5F-F7F1-48D8-85A2-6E2CB22EF525Q34467407-1967EAF7-A40E-4444-B75C-8963706A4553Q35602343-29F44BA6-6463-43ED-912C-7D72FB3AB4C5Q36157649-9D474C1C-5167-4CE2-947B-3585D6134CA0Q36214378-F9B205A5-8426-4C87-880E-186543951645Q36426297-F4B32D51-62AD-4313-BA6D-49DADF8EFE74Q36963432-D96B3539-F5AA-43C5-9A6F-ACAD23F25135Q37308984-168F42F7-4991-4A15-80B7-54E173936974Q37464982-0AEB7512-0AFC-4D3B-B749-EA9779D5531EQ37633437-3D6C8313-6383-4824-B32C-635E36F47618Q38220568-00F70EE5-1519-4FE2-83FF-73A5EF8B8B74Q38646883-3B2FFC53-60D3-4065-88D9-636FC2A761C9Q38647074-D07D0D96-314D-4F9F-96E0-BCC23CBE9973Q38688833-0EF39AB8-9177-4D75-B974-C1372DA94433Q38759421-CA84A2E6-8A43-44D0-AE8F-17C32B566BD8Q38917434-DA885AA9-358A-4385-972D-34663C49CB93Q39033002-A3D765D4-2C34-4E5D-97DA-BE1C294CCB17Q39102188-C31CD246-8052-417C-98C1-1CE961D63DA2Q39102543-1C801CC4-A612-487A-BA30-6D018D2206F2Q39176941-9FB4C595-4BD5-429F-99D5-A345EC3C0400Q41152448-4E8D35C2-0604-42A6-BD5C-86F3C0897693Q41260178-0ADDBB74-0D27-4223-94EA-E6FEF3082AFBQ41362955-03749578-F116-46F0-95DE-A747A6260D55Q47668118-A3183454-0ED2-4186-8109-020EEFBC959BQ47844211-58ECFB2E-5A6B-4348-B3C5-FC80EC860995Q48130498-EB55D729-6883-492B-959F-68A591B51159Q48178388-D4415781-29F7-4B47-9A62-AF3099670143Q51550177-CE830B63-1A2C-49FA-9B28-D1B73CB82893Q51735358-4B798971-3845-4B1B-B136-A6B034956CBFQ55005234-285AE6BD-0EA4-433A-A780-AB0E367252B4Q58094316-52D30108-5581-4628-94D8-417290533D9E
P2860
Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Cannabinoid- and lysophosphati ...... er release at central synapses
@ast
Cannabinoid- and lysophosphati ...... er release at central synapses
@en
type
label
Cannabinoid- and lysophosphati ...... er release at central synapses
@ast
Cannabinoid- and lysophosphati ...... er release at central synapses
@en
prefLabel
Cannabinoid- and lysophosphati ...... er release at central synapses
@ast
Cannabinoid- and lysophosphati ...... er release at central synapses
@en
P2860
P50
P921
P356
P1476
Cannabinoid- and lysophosphati ...... er release at central synapses
@en
P2093
Ruth A Ross
P2860
P304
P356
10.1073/PNAS.1211204110
P407
P577
2013-03-07T00:00:00Z